Articles by Disease (Spinal Cord Vascular Diseases)

Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm

Journal: Current Pharmaceutical Design
Volume: 10
Page: 2185-2192
Author(s): W. M. Armstead

Neuroprotection by the α2-Adrenoceptor Agonist, Dexmedetomidine, in Experimental Stroke Models

Journal: Vascular Disease Prevention (Discontinued)
Volume: 1
Page: 117-122
Author(s): Kirsi Puurunen, Jukka Jolkkonen and Juhani Sivenius

Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1
Page: 233-252
Author(s): Joanna Bandorowicz-Pikula

Peptide Metabolism and the Control of Body Fluid Homeostasis

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2
Page: 219-238
Author(s): P. F. Silveira, J. Gil, L. Casis and J. Irazusta

Cytochrome P450 in Neurological Disease

Journal: Current Drug Metabolism
Volume: 5
Page: 225-234
Author(s): M. Liu, P. D. Hurn and N. J. Alkayed

Therapeutic Potential of Janus Kinase 3 (JAK3) Inhibitors

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1767-1784
Author(s): M. Cetkovic-Cvrlje and H. E. Tibbles

PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1519-1536
Author(s): Aren van Waarde, Willem Vaalburg, Petra Doze, Fokko J. Bosker and Philip H. Elsinga

Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Journal: Current Cancer Drug Targets
Volume: 4
Page: 267-283
Author(s): X. Chen, S. Wang, N. Wu and C. S. Yang

ABC Transporters and the Blood-Brain Barrier

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1295-1312
Author(s): David J. Begley

Drug Delivery Systems for Brain Tumor Therapy

Journal: Current Pharmaceutical Design
Volume: 10
Page: 1341-1353
Author(s): Jarkko Rautioa and Prashant J. Chikhale